The London biotech's Series C values it at $800 million and funds EDEN models aimed at rewriting a patient's cells…
DeepMind's open AlphaGenome Atlas maps how all nine billion possible single-letter DNA changes could matter.
An ARPA-H contract backs a plan to build an AI-ready dataset covering hundreds of rare conditions.
Stowers' PISA method maps what DNA models learn base by base and scrubs hidden lab bias from genomic data.
LifeMine is reviving its fungal genome platform with $188M from Bill Gates, Jeff Bezos and RA Capital, and will soon…
OpenAI will give up to 100,000 academic researchers free access to frontier models, including 75-plus life-science tools for genomics and…
Scientists at Mount Sinai developed a gene set foundation model that learns how genes behave across thousands of biological contexts,…
AI is reshaping pharmaceutical R&D from target identification through clinical trial optimization, compressing drug discovery timelines and unlocking therapeutic targets…